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Abstract
Rothmund–Thomson syndrome (OMIM #268400) is a severe autosomal recessive genodermatosis: characterised by growth
retardation, hyperpigmentation and frequently accompanied by congenital bone defects, brittle hair and hypogonadism.
Mutations in helicase RECQ4 gene are responsible for a subset of cases of RTS. Only six mutations have been reported,
thus, far and each affecting the coding sequence or the splice junctions. We report the first homozygous mutation in RECQ4
helicase: 2746–2756-delTGGGCTGAGGC in IVS8 responsible for the severe phenotype associated with RTS in a Malaysian
pedigree. We report also a 5321 G → A transition in exon 17 and the updated list of the RECQ4 gene mutations.
© 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Rothmund–Thomson syndrome (OMIM #268400)
shows many analogies with Werner (OMIM # 277700)
and Bloom (OMIM #210900) syndromes. These auto-
somal recessive disorders are associated with genomic
instability and a predisposition to malignancy and/or
premature ageing. WRN gene is defective in Werner
syndrome, BLM in Bloom syndrome and RECQ4 has
been associated to Rothmund–Thomson syndrome.
Many evidences link Rothmund–Thomson syndrome
∗ Corresponding author. Tel.: +39-2-503-15849;
fax: +39-2-503-15864.
E-mail address: ludovica.volpi@unimi.it (L. Volpi).
to helicases RECQ4: three individuals from two pedi-
grees [1] presented the first mutations in RECQ4
gene, and recently another family with two affected
individuals. All these patients carried two compound
mutations in the gene [2]. Moreover, some RTS pa-
tients had no mutations in the RECQ4 helicase. These
data suggest a certain degree of heterogeneity in the
syndrome [3]. Contract grant sponsor: Top Down
project under the Ministry of Science, Technology
and Environment, Malaysia; Contract Grant number:
06-05-01-T001, AIRC.
The inbred Malaysian pedigree (Fig. 1) that we
present in this paper shows an unusual mutation in
RECQ4 gene in two fraternal twins in the fourth
generation, while both the parents and the grand-
0027-5107/02/$ – see front matter © 2002 Elsevier Science B.V. All rights reserved.
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Fig. 1. Pedigree of the Malaysian family. In the second generation, the two sisters II-2 and II-7 probably inherited the
2746–2756-delTGGGCTGAGGC deletion and the 5321 G → A transition from one parent. In the third generation, III-1 and III-2 inherited
the allele carrying the two mutations. In the fourth generation, individuals IV-1, IV-6 and IV-8 inherited one copy of the same allele.
IV-4 and IV-5 inherited two copies of the deleted allele. Individuals I-1, I-2, II-1, IV-2 and IV-3 died before the genetic testing, and
individuals II-3, II-4, II-5, II-6 were not tested. IV-2 died at age of 7 years due to osteosarcoma, IV-3 died due to pneumonia, IV-8 died
at 4 months. Closed symbols denote clinically affected individuals and dotted symbols the carriers.
Fig. 2. (A) The homozygous (top) 2746–2756-delTGGGCTGAGGC mutation detected in individuals IV-4 and IV-5; (bottom) the same
mutation in heterozygosity in III-1, III-2, IV-1, IV-6 and IV-8. (B) The homozygous (top) 5321 G → A transition in individual IV-4 and
IV-5; (bottom) the same mutation in heterozygosity in III-1, III-2, IV-1, IV-6 and IV-8.
mothers are heterozygous carriers for the mutation: a
2746–2756-delTGGGCTGAGGC (Fig. 2A) in IVS8.
We also describe a 5321 G → A transition leading
to R1006Q missense mutation present in the same
family. The RECQ4 allele containing the deletion
does not produce a normal transcript, and the se-
quence of the RT-PCR products shows that IVS8 is
not spliced correctly in the deleted alleles. This is the
first homozygous mutation reported in RECQ4 gene
associated with the Rothmund–Thomson syndrome.
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Table 1
Tm (◦C) bp Forward primer Reverse primer
61 465 g34FP 5′-GGAGATTCGCTGGACGAT-3′ g499RP 5′-AAACAGGGAAGTGGGAGGAG-3′
55 440 FP121 5′-GCACTCTGAAGCGTACCACG-3′ RP334 5′-CTGCAGGGTGCCTTTCAGATT-3′
62 523 1F 5′-AATCGGGCTGCGACCAAGAG-3′ 1R 5′-AGCTGTGGAGGCTCATCACT-3′
Internal primer in primer 1F/1R product: FP241 5′-ACCAAGAGTCCACAGCCTAC-3′
56 198 FP392 5′-GAAGAGCCTCATCTAAGGCA-3′ RP571 5′-TCACTGTGACATCGCTGTAA-3′
62 867 2F 5′-AGTGATGAGCCTCCACAGCT-3′ 4R 5′-CCAGTGATCGAACTGCTCGTT-3′
58 274 2F 5′-AGTGATGAGCCTCCACAGCT-3′ 2R 5′-ATGCTGACTTCTTGGAAG-3′
62 524 2F 5′-AGTGATGAGCCTCCACAGCT-3′ 3R 5′-AGCCCTAGCTTGACTGGAGG-3′
62 610 3F 5′-CTTCCAAGAAGTCAGCATCC-3′ 4R 5′-CCAGTGATCGAACTGCTCGTT-3′
62 362 4F 5′-CCTCCAGTCAAGCTAGGGCT-3′ 4R 5′-CCAGTGATCGAACTGCTCGTT-3′
57 741 FP132 5′-AGCATGGAAGCAGAAGTGGC-3′ 5R 5′-TGGAGATGCCAGACAGGATC-3′
55 657 5F 5′-AACGAGCAGTTCGATCACTGG-3′ 5R 5′-TGGAGATGCCAGACAGGATC-3′
63 785 FP1387 5′-ATCTGTGTCTGCAGAGACGCC-3 Q4C3R 5′-TGGTCATGCCCGAGTGTATGC-3′
Internal primer in primer 1387/RQ4CR product: RP1611 5′-CTTTGACCTGCTGCCAAGACT-3′
55 433 Q4C8 5′-GGAAATGTGCTGGGAAAGGAG-3′ Q4C5 5′-ACCAGTGCCTCAGGTGTCAGC-3′
55 989 FP1387 5′-ATCTGTGTCTGCAGAGACGCC 6R 5′-AGCAACTGGAGGCAGCTGTG-3′
61 310 FP173T 5′-GATGCTGACACCTGAGGCAC-3 RP1941 5′-GTGCCACGTCACTGGCAGTG-3′
55 797 FP1871 5′-AGGTGAGCCATATGTGAACT-3′ 8R 5′-CTGCACGTAGCTCTCGAAGC-3′
55 873 7F 5′-CACAGCTGCCTCCAGTTGCT-3′ 8R 5′-CTGCACGTAGCTCTCGAAGC-3′
55 429 9F 5′-GCTTCGAGAGCTACGTGCAG-3′ 9R 5′-CTGTACGGTAAGCTGTATTG-3′
55 506 E15FP 5′-AGAGCTGGTGTCCCCGTGGAC Q4E15RP 5′-TGGGAACACGCGCTGTACCAG-3′
64 565 FP2636 5′-CTCAAGAGGCTGAGCAGCTTAG 10R 5′-GGCTCGTGGTCCCACTGCAG-3′
58 488 10F 5′-CAATACAGCTTACCGTACAG-3′ 10R 5′-GGCTCGTGGTCCCACTGCAG-3′
55 278 FP2961 5′-TTTGACATGGTCAAGCTGGTGGA RP3149 5′-CCATAGAGGAAGTCACATATCT-3′
61 492 FP2961 5′-TTTGACATGGTCAAGCTGGTGGA 11R 5′-AGGTCCTTGAGCCTGGTGCT-3′
55 423 11F 5′-CTGCAGTGGGACCACGAGCC-3′ 11R 5′-AGGTCCTTGAGCCTGGTGCT-3′
60 577 12F 5′-AGCACCAGGCTCAAGGACCT-3′ 12R 5′-GCCACCTGCAGGAGCTCTTC-3′
62 325 FP3485 5′-CATCTTCCACGGCATCGG-3′ Q4A8RP-GTCACTGCCCTAGCCTCTGACAAC-3′
2. Materials and methods
Sequencing analysis was performed on DNA ex-
tracted from peripheral blood lymphocytes (Wizard®
Genomic, Promega). PCR was carried out with the
primers reported in Table 1 based on the sequence
(EMBL/GenBank accession number AB026546). The
samples were then sequenced with the ABI PRISMTM
BigDye Terminator Cycle Sequencing Ready Reac-
tion Kit Ver 2 on ABI PRISMTM 310 Genetic Anal-
yser. Internal primers were used in the sequencing
reactions.
RT-PCR and sequencing: First strand cDNA was
synthesised from 2g of total RNA (Rnazolo-Gibco
BRL Life Technologies Ltd., Paisley Scotland, UK)
with oligodT primer (Riboclone cDNA Synthesis
System, Promega, Madison, WI). Ten microliter of
the first strand was amplified in a total volume of
100l containing specific mRNA RECQ4 primers
(EMBL/GenBank accession number XM 005151.3|).
Forward primer 5′-TGTCACAGTGAGGTCCCAGA
is in exon 5 and the reverse primer 5′-ACACCTGGTC-
ATCCATGAGT overlaps the junctions between exons
9 and 10. Twenty amplification cycles were performed
at an annealing temperature of 56 ◦C. The ampli-
fied 1044 bp fragment was sequenced with the ABI
PRISMTM BigDye Cycle Sequencing Ready Reaction
Kit Ver 2 on ABI PRISMTM 310 Genetic Analyser.
3. Case reports
Rothmund–Thomson syndrome is a rare genoder-
natosis with variable clinical expression. The main
features include: proportionate dwarfism, premature
ageing, skin hyperpigmentation appearing within
the first semester of life and longlife persisting,
102 P. Balraj et al. / Mutation Research 508 (2002) 99–105
poikiloderma, telengiectasia, brittle hair sometimes
progressing to total alopecia, distrophic nails, juvenile
cataract, photosensitivity and congenital skeletal de-
fects as hypoplasia or absence of the radii and thumbs.
This set of fraternal twins presented at the age of
10 months and based on the clinical features was di-
agnosed to have Rothmund–Thomson syndrome.
The male twin (IV-4) developed multicentric os-
teosarcoma at the age of 14 years involving the left
humerus and the right tibia. He received chemotherapy
and underwent resection of the limb salvage surgery
for the tumour over the left humerus. However, he had
to undergo an above knee amputation as the tibial tu-
mour recurred. He is currently free of disease 5 years
after stopping therapy.
His sister (IV-5) developed osteosarcoma of the left
humerus at the age of 15 years. She also received
chemotherapy and underwent limb salvage surgery.
However, she developed metastases in her lungs and
succumbed to the disease.
4. Results
The four generation pedigree with three members
affected by in the last generation (Fig. 1) offered a
unique chance to assess the link between RECQ4 gene
and RTS. Cytogenetic analysis of the Malaysian kin-
dred has been reported previously [4].
We amplified and sequenced the whole RECQ4
gene in the affected members of this family IV-4
and IV-5 (Fig. 1), and aligned the sequence with
the reported genomic sequence [5]. We found two
Fig. 3. Difference in electrophoretic mobility of the RT-PCR products spanning exons 5–9. Lane C: the correctly spliced fragment is
1044 bp long in the control. Lanes IV-4 and IV-5 show a 66 bp longer fragment due to the non-excision of IVS8. Lane III-1 shows two
bands, according with the carrier status for the mutation (marker: M).
new mutations: a 2746–2756-delTGGGCTGAGGC
in IVS8 (Fig. 2A), and a 5321 G → A transition
in exon 17 (Fig. 2B). The deletion shortens the
IVS8 from 77 down to 66 bp. To evaluate the role
of the intronic deletion in the splicing process we
performed the RT-PCR analysis of RECQ4 gene:
forward primer 5′-TGTCACAGTGAGGTCCCAGA
is based on the sequence of exon 5 and the reverse
primer 5′-ACACCTGGTCATCCATGAGT overlaps
the junctions between exons 9 and 10. The ampli-
fied sequence spans from exons 5 to 9. The spliced
fragment is 1044 nts long (lane C), while the two
affected members IV-4 and IV-5 share a fragment
1100 basepairs long. The father (lane III-1) has both
the transcripts (Fig. 3). The sequence analysis shows
that IVS8 has not been spliced out during transcrip-
tion (Fig. 4). However, the deletion does not affect
the canonical splicing elements, as the donor and
the acceptor sites are conserved, as was the branch
site (Fig. 4). As IVS8 is not spliced out, the deletion
introduces a frameshift mutation and the translation
terminates at a termination signal within the intron
(Fig. 4), creating a truncated protein.
In the same family, we found another mutation a
5321 G → A transition leading to R1006Q missense
mutation.
Analysis of the pattern of inheritance of the two
mutations in the family members, whose samples was
available for testing resulted in: II-2 and II-7, III-1
and III-2 and IV-1, IV-6, IV-8 being heterozygous,
and IV-4 and IV-5 homozygous (Fig. 1). IV-7 is the
only member tested in the last generation who did not
inherited the RECQ4 deleted allele. The pattern of
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Fig. 4. Partial sequence of the RECQ4 human genomic sequence, including the donor and acceptor sites of IVS8. The RECQ4 human
cDNA sequence following correct splicing and the cDNA sequence in patient IV-4. The intronic sequence is in italics and the TGA
termination signal that terminates translation in the deleted alleles is in bold. Ten (GGGCTGAGGC) out of 11 (TGGGCTGAGGC) deleted
residues are repeated in tandem.
Fig. 5. Genomic structure of human RECQ4 gene. The boxes (1–21) and intervening lines indicate exons and introns. The total length is
6462 nucleotides (accession number AB026546). The filled boxes (8–14) indicate the helicase domain. The arrows indicate the mutations
reported in RTS patients and the arrowheads the polymorphisms.
transmission is observed to be the same for both the
mutations.
Fig. 5 presents a schematic diagram of the gene
and a mutations update in RECQ4 gene. All mutations
(except Mut-2) are in the helicase region of the gene
spanning from exons 8 to 14 [1,5].
5. Discussion
The gene responsible for RTS syndrome is RECQ4
(#268400). The symbol (#) before the entry number
means that the phenotype can be caused by mutation
in 2 or more genes. Mutations in RECQ4 gene are not
associated with all patients with RTS except with the
three families reported, thus, far to have compound
heterozygous in their affected members, and the lack
of mutations in some patients suggests a certain level
of heterogeneity in the syndrome [3]: the present find-
ing strengthens the association between this gene and
RTS phenotype.
The pedigree (Fig. 1) shows a high degree of con-
sanguinity: the parents of the affected are first cousins.
This allowed us to trace back the transmission of the
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mutation in the family tree and to describe the first
homozygous mutation in RECQ4 gene, present in two
different affected individuals. In the same family stud-
ied, another child died of RTS, but no samples were
available from this individual as he had passed away
before the whole family was tested. Amplification and
sequencing of RECQ4 gene has revealed the intronic
11 bp deletion 2746–2756-delTGGGCTGAGGC
(Fig. 2A). RT-PCR (Fig. 3) and sequencing results
(Fig. 4) show that the IVS8 partial deletion affects
splicing: RECQ4 mRNA results 66 residues longer
and the reading frame is shifted introducing a termi-
nation signal (Fig. 4): the predicted product is 501
amino acids compared to the full-length 1208 amino
acids [1]. Thus, the effect of this mutation would be
“loss-of-function” type. This finding could account
for the severe phenotype in this family: IV-2 died at
age 7, IV-5 died at age 15 and the twin brother IV-4
at age 13 had a multicentric osteosarcoma. The other
mutation running in the family is the 5321 G → A
transition in exon 17 leading to R1006Q missense
mutation (Fig. 2B). This mutation is located down-
stream from the splice site mutation and would result
in a premature stop codon in this family. This tran-
sition is considered a polymorphism as its presence
has been identified in the normal population (3 out of
20 unrelated individuals tested). We also rule out any
of its association with RTS as the mouse genome has
a glutamine in the corresponding codon 1015 [6].
These considerations suggest that the IVS8 par-
tial deletion is the only mutation responsible for the
Rothmund–Thomson syndrome in this kindred.
RTPCR results show that the deletion leads to
a wrong spliced mRNA and this would eventually
lead to a truncated protein with very limited helicase
domain. But how can an intronic deletion affect so
severely the splicing machinery? The reported dele-
tion is quite embedded within the intron (Fig. 4) 27
nts from the 5′ donor splice site and 40 nts from the
3′ acceptor splice site and does not alter the splice
donor or the acceptor site or the branch site. Fur-
thermore, it is almost duplicated inside the intron, 10
out of 11 bases are repeated in tandem (Fig. 4), and
no variations have been found in the exon-regulatory
sequences such as splicing enhancer elements [7].
Some new reports have associated a disease with an
intronic mutation not affecting the canonical sites. In
fact, the interest for these mutations has increased and
may account for the some “heterogeneous” syndromes
where intronic sequences could have been neglected.
The very limited size of the intron, reduced from 77
to 66 bases, may account for the abnormal splicing
[8], preventing the correct formation of the lariat. In
a Thai family, a 20 bp intronic deletion led to auto-
somal dominant polycystic kidney disease (ADPKD):
the deletion prevents the transcription of the preced-
ing exon 43 [9]. Another report showed that removal
of GTAA residues from an intronic sequence in ATM
gene caused a splicing processing defect; the deletion
uncouples completely the U1 snRNP binding causing
the activation of a cryptic exon [10]. These novel mu-
tations describe how delicate the interactions between
splicing and the intronic sequence are.
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